1. Home
  2. Analysis

Pulmonary embolism and drugs of ingredients of clobazam (a real world drug study)


Summary:

Pulmonary embolism is found among people who take drugs with ingredients of clobazam, especially for people who are male, 20-29 old . This phase IV clinical study is created by eHealthMe based on reports of 21,853 people who have side effects when taking drugs with ingredients of clobazam from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Clobazam, Onfi, Sympazan.

On Aug, 12, 2026

21,853 people reported to have side effects when taking drugs with ingredients of clobazam.
Among them, 39 people (0.18%) have Pulmonary embolism

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,335 drugs and 2,959 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

Number of reports submitted per year:

Could drugs with ingredients of clobazam cause Pulmonary embolism?

Gender of people who have Pulmonary embolism when taking drugs with ingredients of clobazam *:

  • female: 37.84 %
  • male: 62.16 %

Age of people who have Pulmonary embolism when taking drugs with ingredients of clobazam *:

  • 0-1: 0.0 %
  • 2-9: 2.7800000000000002 %
  • 10-19: 0.0 %
  • 20-29: 30.56 %
  • 30-39: 25.0 %
  • 40-49: 13.89 %
  • 50-59: 19.44 %
  • 60+: 8.33 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Insomnia (sleeplessness): 7 people, 17.95%
  2. Depression: 6 people, 15.38%
  3. Fever: 6 people, 15.38%
  4. High Blood Pressure: 6 people, 15.38%
  5. Anaemia (lack of blood): 5 people, 12.82%
  6. Partial Seizures (seizures which affect only a part of the brain at onset): 5 people, 12.82%
  7. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 4 people, 10.26%
  8. Arterial Disorder: 4 people, 10.26%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 10.26%
  10. Device Related Infection: 4 people, 10.26%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Cannabis: 10 people, 25.64%
  2. Keppra: 6 people, 15.38%
  3. Sodium Bicarbonate: 6 people, 15.38%
  4. Pantoprazole: 5 people, 12.82%
  5. Paroxetine: 5 people, 12.82%
  6. Hydrocortisone: 4 people, 10.26%
  7. Vitamin K: 4 people, 10.26%
  8. Leucovorin Calcium: 4 people, 10.26%
  9. Lamictal: 4 people, 10.26%
  10. Kayexalate: 4 people, 10.26%

Other side effects people have besides Pulmonary embolism *:

You may use this to check any potential undetected side effects.

  1. Pneumonia Necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs): 9 people, 23.08%
  2. Cardiac Arrest: 9 people, 23.08%
  3. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 23.08%
  4. Head Injury: 8 people, 20.51%
  5. Rickets (softening of bones): 6 people, 15.38%
  6. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 12.82%
  7. Weakness: 4 people, 10.26%
  8. Bradycardia (abnormally slow heart action): 4 people, 10.26%
  9. Breathing - Slowed Or Stopped: 4 people, 10.26%
  10. Face Oedema (swelling of face): 4 people, 10.26%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of clobazam, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on clobazam. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.